Search research articles
Contact Us
Filters
Showing results (221-230 of 273) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2015
Reply to E.A. Rakha et al
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Molecular Cancer Therapeutics
|
November 5, 2016
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
Michael F Press, Catherine E Ellis, Robert C Gagnon, et al.
Genome Medicine
|
May 7, 2026
African ancestry and risk variants associated with triple-negative breast cancer susceptibility in African American women
Guochong Jia, Lili Liu, Jie Ping, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial
J Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
Archives of Pathology & Laboratory Medicine
|
October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Human Genetics
|
July 6, 2016
Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry
Frank Qian, Ye Feng, Yonglan Zheng, et al.
Cancer Discovery
|
October 12, 2019
Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers
Remi Klotz, Amal Thomas, Teng Teng, et al.
Nature Communications
|
November 18, 2020
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Sara A Hurvitz, Jennifer L Caswell-Jin, Katherine L McNamara, et al.
Annals of Epidemiology
|
May 4, 2002
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results
Polly A Marchbanks, Jill A Mcdonald, Hoyt G Wilson, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 273) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2015
Reply to E.A. Rakha et al
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Molecular Cancer Therapeutics
|
November 5, 2016
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
Michael F Press, Catherine E Ellis, Robert C Gagnon, et al.
Genome Medicine
|
May 7, 2026
African ancestry and risk variants associated with triple-negative breast cancer susceptibility in African American women
Guochong Jia, Lili Liu, Jie Ping, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial
J Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
Archives of Pathology & Laboratory Medicine
|
October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Human Genetics
|
July 6, 2016
Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry
Frank Qian, Ye Feng, Yonglan Zheng, et al.
Cancer Discovery
|
October 12, 2019
Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers
Remi Klotz, Amal Thomas, Teng Teng, et al.
Nature Communications
|
November 18, 2020
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Sara A Hurvitz, Jennifer L Caswell-Jin, Katherine L McNamara, et al.
Annals of Epidemiology
|
May 4, 2002
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results
Polly A Marchbanks, Jill A Mcdonald, Hoyt G Wilson, et al.
Page
of 28